Krystal Biotech (KRYS) Insider Trading & Ownership $161.91 -6.66 (-3.95%) As of 04/21/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Krystal Biotech (NASDAQ:KRYS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage13.70%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$21.32 M Get KRYS Insider Trade Alerts Want to know when executives and insiders are buying or selling Krystal Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address KRYS Insider Buying and Selling by Quarter Krystal Biotech Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/13/2025Suma KrishnanInsiderSell25,000$177.79$4,444,750.00 2/27/2025Kathryn RomanoCAOSell750$175.22$131,415.00 12/13/2024Suma KrishnanInsiderSell25,000$164.78$4,119,500.00 9/12/2024Suma KrishnanInsiderSell25,000$197.76$4,944,000.00 6/11/2024Suma KrishnanInsiderSell25,000$175.76$4,394,000.00 5/20/2024Julian S. GangolliDirectorSell20,000$164.13$3,282,600.00 (Data available from 1/1/2013 forward) KRYS Insider Trading Activity - Frequently Asked Questions Who is on Krystal Biotech's Insider Roster? The list of insiders at Krystal Biotech includes Andrew C Orth, Daniel Janney, Dino A Rossi, Julian S. Gangolli, Kathryn Romano, Krish S Krishnan, and Suma Krishnan. Learn more on insiders at KRYS. What percentage of Krystal Biotech stock is owned by insiders? 13.70% of Krystal Biotech stock is owned by insiders. Learn more on KRYS's insider holdings. Which Krystal Biotech insiders have been selling company stock? The following insiders have sold KRYS shares in the last 24 months: Andrew C Orth ($1,607,625.00), Daniel Janney ($10,282,391.15), Julian S. Gangolli ($3,282,600.00), Kathryn Romano ($7,821,087.57), and Suma Krishnan ($30,902,750.00). How much insider selling is happening at Krystal Biotech? Insiders have sold a total of 400,430 Krystal Biotech shares in the last 24 months for a total of $53,896,453.72 sold. Krystal Biotech Key ExecutivesMr. Krish S. Krishnan M.B.A. (Age 59)M.S., Founder, Chairman, President & CEO Compensation: $1.32MMs. Suma M. Krishnan (Age 59)Founder, President of R&D and Director Compensation: $895.33k2 recent tradesMs. Kathryn A. Romano (Age 42)Executive VP & Chief Accounting Officer Compensation: $614.87k1 recent tradesMr. John ThomasGeneral Counsel & Corporate SecretaryMr. John KarakkalVice President of North American Sales & MarketingMs. Christine WilsonHead of U.S. Sales & MarketingDr. Stephane Paquette Ph.D.Vice President of Corporate DevelopmentMr. Josh SuskinDirector of Human Resources & OperationsMr. Laurent GouxSenior VP & GM of EuropeMr. David ChienSenior Vice President of Clinical Development More Insider Trading Tools from MarketBeat Related Companies Summit Therapeutics Insider Transactions Teva Pharmaceutical Industries Insider Transactions Intra-Cellular Therapies Insider Transactions Genmab A/S Insider Transactions Moderna Insider Transactions Viatris Insider Transactions Roivant Sciences Insider Transactions Lantheus Insider Transactions Revolution Medicines Insider Transactions BridgeBio Pharma Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Beware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1 This page (NASDAQ:KRYS) was last updated on 4/22/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'Introducing your AI trading partner. You don't need to stare at charts, stress over setups, or lose sleep. ...Blue Edge Financial | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredThey Scared The Nation And Cashed in on ChaosYou weren’t supposed to notice what just happened. While the headlines screamed about tariffs and Trump, Wa...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Krystal Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Krystal Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.